Keywords: germany, schering, ag, outlines, prospects, future, growth
Germany's Schering AG outlines prospects for future growth
Article | 11 March 2002
Having recently announced 2001 net sales of 4.84 billion euros ($4.21billion; +8%) and a 24% rise in net income to 418 million euros (Marketletter February 11), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
